Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec:167:209517.
doi: 10.1016/j.josat.2024.209517. Epub 2024 Sep 17.

An economic analysis of the cost of mobile units for harm reduction, naloxone distribution, and medications for opioid use disorder

Mathieu Castry  1 , Yjuliana Tin  2 , Noah M Feder  3 , Nikki Lewis  4 , Avik Chatterjee  5 , Maria Rudorf  4 , Jeffrey H Samet  5 , Donna Beers  4 , Bethany Medley  6 , Louisa Gilbert  6 , Benjamin P Linas  7 , Joshua A Barocas  8
Affiliations

An economic analysis of the cost of mobile units for harm reduction, naloxone distribution, and medications for opioid use disorder

Mathieu Castry et al. J Subst Use Addict Treat. 2024 Dec.

Abstract

Background & objective: Mobile substance use treatment units are effective approaches to increase treatment access and reduce barriers to opioid use disorder (OUD) care. However, little is known about the economic costs of maintaining and operating these units. This study aimed to estimate the economic costs of starting and maintaining mobile units providing harm reduction, overdose education and naloxone distribution (OEND), and medication for opioid use disorder (MOUD).

Methods: As part of the HEALing Communities Study, four communities in Massachusetts (Bourne/Sandwich, Brockton, Gloucester, Salem) implemented mobile units offering OEND and MOUD (buprenorphine and naltrexone only); each selected different services tailored to their community. All provided MOUD linkage via telehealth, but only one offered in-person MOUD prescribing on the unit. We retrospectively collected detailed resource utilization data from invoices to estimate the direct economic costs from August 2020 through June 2022. Cost components were categorized into start-up and operating costs. We calculated total economic cost over the study period and the average monthly operating cost.

Results: Implementing a mobile unit offering OEND and MOUD required a one-time median start-up cost of $59,762 (range: $52,062-$113,671), with 80 % of those costs attributed to the vehicle purchase. The median monthly operating cost was $14,464. The largest cost category for all mobile units was personnel costs. The monthly ongoing costs varied by community settings and services: approximately $5000 for two urban communities offering OEND and MOUD linkage via telehealth (Gloucester, Salem), $28,000 for a rural community (Bourne/Sandwich), and $23,000 for an urban community also providing in-person MOUD prescribing on the unit (Brockton).

Conclusion: The economic costs of mobile substance use treatment and harm reduction units are substantial but vary by community settings and services offered. Our results provide valuable community-level economic data to stakeholders and policymakers considering establishing and/or expanding mobile units with OEND and MOUD services. Further exploration of cost-effectiveness and efficiency should be considered across different settings.

Keywords: Economic evaluation; Harm reduction; Medications for opioid use disorder; Mobile health units; Opioid use disorder.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Similar articles

See all similar articles

Cited by

References

    1. Attipoe-Dorcoo S, Delgado R, Lai D, Gupta A, & Linder S (2020). Analysis of Annual Costs of Mobile Clinics in the Southern United States. Journal of Primary Care & Community Health, 11, 2150132720980623. 10.1177/2150132720980623 - DOI - PMC - PubMed
    1. Bartholomew TS, Patel H, McCollister K, Feaster DJ, & Tookes HE (2021). Implementation and first-year operating costs of an academic medical center-based syringe services program. Harm Reduction Journal, 18(1), 116. 10.1186/s12954-021-00563-8 - DOI - PMC - PubMed
    1. Bearnot B, Fine DR, Rigotti NA, & Baggett TP (2019). Access to Treatment for Drug Use Disorders at US Health Centers: A National Study. Journal of General Internal Medicine, 34(12), 2723–2725. 10.1007/s11606-019-05043-1 - DOI - PMC - PubMed
    1. Behrends CN, Paone D, Nolan ML, Tuazon E, Murphy SM, Kapadia SN, Jeng PJ, Bayoumi AM, Kunins HV, & Schackman BR (2019). Estimated impact of supervised injection facilities on overdose fatalities and healthcare costs in New York City. Journal of Substance Abuse Treatment, 106, 79–88. 10.1016/j.jsat.2019.08.010 - DOI - PubMed
    1. Berk J (2023). Mobile health units: Paving the way for a new era of methadone treatment. Journal of Substance Use and Addiction Treatment, 155, 209160. 10.1016/j.josat.2023.209160 - DOI - PMC - PubMed

MeSH terms